ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis

ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis

Abstract Background Non-alcoholic Fatty Liver Disease (NAFLD), now better known as Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD) and its progression to Nonalcoholic Steatohepatitis (NASH), more recently referred to as Metabolic (Dysfunction)-Associated Steatohepatitis (MASH) are the...

Full description

Bibliographic Details
Main Authors: Paolo Convertini, Anna Santarsiero, Simona Todisco, Michele Gilio, Donatella Palazzo, Ilaria Pappalardo, Dominga Iacobazzi, Maria Frontuto, Vittoria Infantino
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Journal of Translational Medicine
Subjects:
ATP citrate lyase (ACLY)
Hepatocytes
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Oxidative stress
NF-kB
Online Access:https://doi.org/10.1186/s12967-023-04431-w

Internet

https://doi.org/10.1186/s12967-023-04431-w

Similar Items